TerraPower reaches market-scale production of Ac-225

October 4, 2024, 9:30AMNuclear News

TerraPower Isotopes, a subsidiary of Bellevue, Wash.–based TerraPower, announced it is now producing actinium-225 at commercial scale, making the medical isotope available to the pharmaceutical industry through weekly production runs. As a result, TerraPower Isotopes said its actinium, after further manufacturing, is now used in multiple drug developers’ radiopharmaceuticals in human clinical trials across the globe.

To continue reading, log in or create a free account!

Related Articles

Tests back shielding plan for Kairos Power

February 27, 2026, 9:29AMNuclear News

Kairos Power has completed shielded radiation performance testing on a full-scale precast concrete structure at the company’s Reactor Demonstration Campus in Oak Ridge, Tenn., involving the...

ANSTO-designed target increases Mo-99 yield

February 25, 2026, 1:00PMNuclear News

The Australian Nuclear Science and Technology Organization (ANSTO) announced that it has made progress on a more cost-effective way to produce the medical radioisotope molybdenum-99, with less...

Centrus to expand Oak Ridge facility

January 26, 2026, 9:38AMNuclear News

Centrus Energy Corp. is planning a major expansion of its Oak Ridge, Tenn., Technology and Manufacturing Center. The build-out would allow it to expedite large-scale deployment of...